List of Content
Global Aortic Valve Replacement Devices Market 2025 – 2034
Aortic Valve Replacement Devices Market Size, Trends and Insights By Product Type (Balloon-expandable, Self-expandable, Mechanically Expandable, Aortic Regurgitation), By Leaflet Material (Bovine Pericardium, Porcine Pericardium, Research Institutes and Others), By End-use (Inpatient Facilities, Outpatient Facilities, Immunoassays, Flow Cytometry, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034
Report Snapshot
| Study Period: | 2025-2034 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | North America |
Major Players
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Others
Reports Description
Global Aortic Valve Replacement Devices Market was valued at USD 7.26 Billion in 2025 and is expected to reach USD 9.24 Billion by 2034, at a CAGR of 2.63% during the forecast period 2025-2034.
Aortic Valve Replacement Devices Market Overview
The aortic valve replacement devices market includes medical devices used for replacing one of the heart valves known as the aortic valve, which ensures the blood flows in one direction from the heart.
The industry encompasses mechanical, bioprosthetic, and transcatheter aortic valves (TAVR). Increasing cases of aortic stenosis, growing popularity of minimally invasive procedures, and improvements in valve durability and surgical techniques are expected to promote the market growth.
Aortic Valve Replacement Devices Market Growth Factors
Rising Prevalence of Aortic Stenosis and Cardiovascular Diseases
Persistent use of aortic stenosis & other CVD continues to propel the aortic valve replacement devices market. These diseases affect millions of people globally, causing complications such as heart failure, fainting, and sudden cardiac death.
The prevalence of moderate to severe aortic stenosis is reported to be as high as 12% in those over 75 years of age, creating a sizable burden for valve replacement. Hospitals have performed more of these procedures in Germany than elsewhere, reducing deaths and allowing patients to recover more quickly after surgery.
At Charité Universitätsmedizin Berlin, they have invested heavily in less invasive valve replacement techniques that allow more patients to be treated in a timely manner. To tackle it, governments and healthcare providers respond with increased funding for heart disease research and expanded access to specific cardiac care, which adds to the growth of the market around the globe.
Advancements in Aortic Valve Replacement Technologies
The durability of aortic valve replacement devices, the implantation techniques, and the outcomes of the patients have improved with the development of more sophisticated technologies. As an example, excellent hemodynamic performance along with absence of complications is offered by both Evolut PRO+ (Medtronic) and SAPIEN 3 Ultra (Edwards Lifesciences).
This is especially good news for patients who are not candidates for an open-heart procedure. Canada has been using self-expanding transcatheter heart valves at centers like Toronto General Hospital for several years already, and the results have reduced the number of surgeries required by as much as 75 percent. AI-assisted imaging and real-time procedural monitoring have been introduced in medical centers, increasing accuracy and decreasing risk.
So, the researchers have modified valve designs for 3D printing and developed implants that would lead to better outcomes that are tailor-made for the patients. As material science and catheter technologies continue to advance, the market will see even greater innovations, delivering safer, lower-risk options for aortic valve replacement.
Expanding Healthcare Infrastructure in Emerging Markets
The development of healthcare infrastructure in emerging economies involved huge investments; domestic growth barriers, therefore, have to a large extent targeted mainly health accessibilities to reach into aortic valve replacement procedures.
In India, China, Brazil, and other countries, cardiovascular care facilities have been opened or expanded to be able to provide complex, advanced care to more patients. The All-India Institute of Medical Sciences (AIIMS) in India has multiplied its cardiovascular surgery department and ramped up the annual number of valve replacement operations.
The Ayushman Bharat program has expanded the access of lower-income populations to TAVR and SAVR procedures, enabling a greater proportion of patients to benefit from advanced heart valve technologies. By the same token, Brazil also incorporated public-private partnerships (PPPs) to assist with cardiovascular research funding so that hospitals are able to deliver advanced valve replacement procedures.
Medical device companies are expected to continue expansion in these regions while developing stronger distribution networks and decreasing the costs of devices, therefore driving the market as healthcare policies develop.
Aortic Valve Replacement Devices Market Restraints
High Cost of Aortic Valve Replacement Procedures.
Many patients lose the chance for life-saving treatment, especially in lower- and middle-income countries, because the costs of aortic valve replacement procedures are prohibitive. TAVR procedures often run between USD 30,000 and USD 50,000 a patient.
Unlike many patients in the United States, who often have help paying for the procedure through insurance companies, patients in South Africa, where TAVRs are performed primarily in private healthcare, may find it difficult to afford out-of-pocket expenses. With no universal healthcare coverage, patients have to settle for more affordable but more dangerous options.
Even in a developed country like the U.S., insurance companies have stringent requirements for reimbursement, and access to advanced procedures and devices is often limited. Such economic obstacles limit the sales of next-generation aortic valve replacement devices, hindering overall market expansion.
Aortic Valve Replacement Devices Market Trends
AI and Robotics in Aortic Valve Replacement
Background: minimally invasive approaches to aortic valve replacement (AVR) can improve surgical precision, real-time intraoperative decision-making, and patient outcomes, and advances in artificial intelligence (AI) and robotic-assisted surgery are finally being integrated into the hospital environment.
AI-assisted imaging systems enable surgeons to make more precise cuts during valve placements, which can reduce the possibility of mistakes and complications.
In the UK, surgeons at King’s College Hospital have performed robotic-assisted TAVR techniques, which have cut down operation times and have improved surgical precision. As analytics driven by AI curls at the margin, further hospitals will take on AI-empowered cardiovascular medications to bolster level substitution both more securely and effectively.
Increasing Demand for Next-Generation Bioprosthetic Valves
The healthcare practitioners are now moving towards the next-generation bioprosthetic aortic valves, which provide superior biocompatibility and permanent anticoagulant-free therapy. Recent advances in tissue engineering and biomaterials have markedly improved the durability of valves, making them increasingly the valve of choice for the younger population.
France sees initial use of longer-lasting Tendyne valve from Abbott; calcium risk reduced. With advances in research yielding longer-lasting and more biologically matured heart valves, innovation in bioprosthetic solutions will continue to be necessary to meet higher patient demand.
Aortic Valve Replacement Devices Market Segmentation Analysis
Based on product type, the global aortic valve replacement devices market is segmented into balloon-expandable, self-expandable, mechanically expandable, and aortic regurgitation. The balloon-expandable aortic valve replacement devices account for the largest market share due to their considerable acceptance.
With a more controlled in-procedural environment, superior hemodynamic profiles, and reduced complication rates, these devices are a preferred option for many cardiologists. For instance, the SAPIEN 3 Ultra valve, currently a state-of-the-art balloon-expandable device from Edwards Lifesciences, has been shown to have improved clinical outcomes, lower paravalvular leaks, and better durability.
Balloon-expandable valves have been adopted in U.S. and European hospitals at an increasing pace as a result of their predictable deployment and low risk of device embolization. Moreover, constant advancements in valve material and delivery systems can keep making balloon-expandable valves more effective to consolidate their market-leading position.
Self-expandable and mechanically expandable devices are expanding segments, particularly in high-risk and inoperable patients, but still have limitations regarding device retrievability, procedural complexity, and long-term freedom from restenosis. Aortic regurgitation valves are used to treat aortic regurgitation but are generally not mainstream products, as aortic stenosis fills the primary market for valve replacement procedures.
Based on end use, the aortic valve replacement devices market is segmented by inpatient facilities and outpatient facilities. Inpatient facilities occupied the largest share of the aortic valve replacement devices market, as the majority of TAVR and SAVR procedures need specialized hospital settings, intensive post-operative care, and advanced cardiac monitoring.
The sophistication of the hybrid ORs at hospitals and specialty cardiac centers is an ideal fit for the high-risk and complex cardiac patients. Moreover, next-generation aortic valves, robotic-assisted surgeries, and AI-driven imaging technologies are all present due to the concentration of government and private healthcare funding into hospitals and large healthcare institutions.
Despite the growing popularity of outpatient facilities as better minimally invasive TAVR techniques are developed, they still cannot provide the extensive postoperative monitoring and acute care that inpatient facilities can. As a result, the market is still largely controlled by hospitals and dedicated cardiac centers.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 7.26 Billion |
| Projected Market Size in 2034 | USD 9.24 Billion |
| Market Size in 2024 | USD 7.13 Billion |
| CAGR Growth Rate | 2.63% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product Type, Leaflet Material, End-use and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Aortic Valve Replacement Devices Market Regional Analysis
North America is estimated to be the dominant global aortic valve replacement devices market in the year 2024 owing to the presence of advanced healthcare infrastructure, high prevalence of aortic stenosis, and rapid growth of advanced medical technologies.
Strong reimbursement policies, high R&D investments, and large populations of trained cardiologists solidify the region as a leader in transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) procedures.
Similarly, Canada plays a huge role in this growth, as organizations such as Toronto General Hospital are heavily investing in artificial intelligence tools for valve replacements, which were observed to provide better procedural accuracy. North America continues to dominate the global market due to the rising geriatric population, the rise in cardiovascular disease burden, and the need for investment in favourable government policies.
Aortic Valve Replacement Devices Market Recent Developments
- In August 2024, Boston Scientific announced CE mark approval of the ACCURATE Prime™ Aortic Valve System, offering TAVR options with precision deployment for more patients with aortic stenosis.
- In May 2024, the SAPIEN 3 Ultra RESILIA valve was released in Europe by Edwards Lifesciences. It has improved RESILIA tissue technology that is meant to make the valve last longer and improve long-term outcomes for people with heart valve disease.
- In April 2024, the Avalus Ultra valve, a next-generation surgical aortic tissue valve launched by Medtronic, is a product of over ten years of clinical experience and is designed to provide ease of use and long-term patient management.
List of the prominent players in the Aortic Valve Replacement Devices Market:
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Artivion Inc.
- Anteris Technologies Ltd.
- JenaValve Technology Inc.
- CryoLife Inc.
- LifeNet Health Inc.
- Thubrikar Aortic Valve Inc.
- Colibri Heart Valve
- Meril Life Sciences Pvt Ltd
- BioTronik
- Coroneo Inc.
- Terumo Corporation
- LeMaitre Vascular
- MicroPort Scientific Corporation
- Nipro Corporation
- Shanghai Kindly Medical Instruments Co. Ltd.
- Others
The Aortic Valve Replacement Devices Market is segmented as follows:
By Product Type
- Balloon-Expandable
- Self-Expandable
- Mechanically Expandable
- Aortic Regurgitation
By Leaflet Material
- Bovine Pericardium
- Porcine Pericardium
- Research Institutes and Others
By End-use
- Inpatient Facilities
- Outpatient Facilities
- Immunoassays
- Flow Cytometry
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Aortic Valve Replacement Devices Market, (2025-2034) (USD Billion)
- 2.2 Global Aortic Valve Replacement Devices Market : snapshot
- Chapter 3. Global Aortic Valve Replacement Devices Market – Industry Analysis
- 3.1 Aortic Valve Replacement Devices Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Prevalence of Aortic Stenosis and Cardiovascular Diseases
- 3.2.2 Advancements in Aortic Valve Replacement Technologies
- 3.2.3 Expanding Healthcare Infrastructure in Emerging Markets.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porters Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Leaflet Material
- 3.7.3 Market attractiveness analysis By End-use
- Chapter 4. Global Aortic Valve Replacement Devices Market-—Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Aortic Valve Replacement Devices Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Aortic Valve Replacement Devices Market – Product Type Analysis
- 5.1 Global Aortic Valve Replacement Devices Market overview: By Product Type
- 5.1.1 Global Aortic Valve Replacement Devices Market share, By Product Type, 2024 and 2034
- 5.2 Balloon-expandable
- 5.2.1 Global Aortic Valve Replacement Devices Market by Balloon-expandable, 2025-2034 (USD Billion)
- 5.3 Self-expandable
- 5.3.1 Global Aortic Valve Replacement Devices Market by Self-expandable, 2025-2034 (USD Billion)
- 5.4 Mechanically Expandable
- 5.4.1 Global Aortic Valve Replacement Devices Market by Mechanically Expandable, 2025-2034 (USD Billion)
- 5.5 Aortic Regurgitation
- 5.5.1 Global Aortic Valve Replacement Devices Market by Aortic Regurgitation, 2025-2034 (USD Billion)
- 5.1 Global Aortic Valve Replacement Devices Market overview: By Product Type
- Chapter 6. Global Aortic Valve Replacement Devices Market – Leaflet Material Analysis
- 6.1 Global Aortic Valve Replacement Devices Market Overview: By Leaflet Material
- 6.1.1 Global Aortic Valve Replacement Devices Market share, By Leaflet Material, 2024 and 2034
- 6.2 Bovine Pericardium
- 6.2.1 Global Aortic Valve Replacement Devices Market by Bovine Pericardium, 2025-2034 (USD Billion)
- 6.3 Porcine Pericardium
- 6.3.1 Global Aortic Valve Replacement Devices Market by Porcine Pericardium, 2025-2034 (USD Billion)
- 6.4 Research Institutes and Others
- 6.4.1 Global Aortic Valve Replacement Devices Market by Research Institutes and Others, 2025-2034 (USD Billion)
- 6.1 Global Aortic Valve Replacement Devices Market Overview: By Leaflet Material
- Chapter 7. Global Aortic Valve Replacement Devices Market – End-use Analysis
- 7.1 Global Aortic Valve Replacement Devices Market overview: By End-use
- 7.1.1 Global Aortic Valve Replacement Devices Market share, By End-use, 2024 and 2034
- 7.2 Inpatient Facilities
- 7.2.1 Global Aortic Valve Replacement Devices Market by Inpatient Facilities, 2025-2034 (USD Billion)
- 7.3 Outpatient Facilities
- 7.3.1 Global Aortic Valve Replacement Devices Market by Outpatient Facilities, 2025-2034 (USD Billion)
- 7.4 Immunoassays
- 7.4.1 Global Aortic Valve Replacement Devices Market by Immunoassays, 2025-2034 (USD Billion)
- 7.5 Flow Cytometry
- 7.5.1 Global Aortic Valve Replacement Devices Market by Flow Cytometry, 2025-2034 (USD Billion)
- 7.6 Others
- 7.6.1 Global Aortic Valve Replacement Devices Market by Others, 2025-2034 (USD Billion)
- 7.1 Global Aortic Valve Replacement Devices Market overview: By End-use
- Chapter 8. Aortic Valve Replacement Device’s Market – Regional Analysis
- 8.1 Global Aortic Valve Replacement Device’s Market Regional Overview
- 8.2 Global Aortic Valve Replacement Device’s Market Share, by Region, 2024 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.3.1.1 North America Aortic Valve Replacement Device’s Market, by Country, 2025-2034 (USD Billion)
- 8.3.1 North America Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.4 North America Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034
- 8.4.1 North America Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034 (USD Billion)
- 8.5 North America Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034
- 8.5.1 North America Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034 (USD Billion)
- 8.6 North America Aortic Valve Replacement Device’s Market, by End-use, 2025-2034
- 8.6.1 North America Aortic Valve Replacement Device’s Market, by End-use, 2025-2034 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.7.1.1 Europe Aortic Valve Replacement Device’s Market, by Country, 2025-2034 (USD Billion)
- 8.7.1 Europe Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.8 Europe Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034
- 8.8.1 Europe Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034 (USD Billion)
- 8.9 Europe Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034
- 8.9.1 Europe Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034 (USD Billion)
- 8.10 Europe Aortic Valve Replacement Device’s Market, by End-use, 2025-2034
- 8.10.1 Europe Aortic Valve Replacement Device’s Market, by End-use, 2025-2034 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.11.1.1 Asia Pacific Aortic Valve Replacement Device’s Market, by Country, 2025-2034 (USD Billion)
- 8.11.1 Asia Pacific Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.12 Asia Pacific Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034
- 8.12.1 Asia Pacific Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034 (USD Billion)
- 8.13 Asia Pacific Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034
- 8.13.1 Asia Pacific Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034 (USD Billion)
- 8.14 Asia Pacific Aortic Valve Replacement Device’s Market, by End-use, 2025-2034
- 8.14.1 Asia Pacific Aortic Valve Replacement Device’s Market, by End-use, 2025-2034 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.15.1.1 Latin America Aortic Valve Replacement Device’s Market, by Country, 2025-2034 (USD Billion)
- 8.15.1 Latin America Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.16 Latin America Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034
- 8.16.1 Latin America Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034 (USD Billion)
- 8.17 Latin America Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034
- 8.17.1 Latin America Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034 (USD Billion)
- 8.18 Latin America Aortic Valve Replacement Device’s Market, by End-use, 2025-2034
- 8.18.1 Latin America Aortic Valve Replacement Device’s Market, by End-use, 2025-2034 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by Country, 2025-2034 (USD Billion)
- 8.19.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, 2025-2034 (USD Billion)
- 8.20 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034
- 8.20.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by Product Type, 2025-2034 (USD Billion)
- 8.21 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034
- 8.21.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by Leaflet Material, 2025-2034 (USD Billion)
- 8.22 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by End-use, 2025-2034
- 8.22.1 The Middle-East and Africa Aortic Valve Replacement Device’s Market, by End-use, 2025-2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Edwards Lifesciences Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Medtronic Plc
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Abbott Laboratories
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Boston Scientific Corporation
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 LivaNova PLC
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Artivion Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Anteris Technologies Ltd.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 JenaValve Technology Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 CryoLife Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 LifeNet Health Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Thubrikar Aortic Valve Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Colibri Heart Valve
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Meril Life Sciences Pvt Ltd
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 BioTronik
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Coroneo Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Terumo Corporation
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 LeMaitre Vascular
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 MicroPort Scientific Corporation
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Nipro Corporation
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Shanghai Kindly Medical Instruments Co. Ltd.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Edwards Lifesciences Corporation
List Of Figures
Figures No 1 to 28
List Of Tables
Tables No 1 to 77
Reports FAQs
The rising prevalence of aortic stenosis and other valvular heart diseases, particularly among the aging population, driving market growth.
The “Balloon-Expandable” category dominated the market in 2024.
The key players in the market are Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Artivion Inc., Anteris Technologies Ltd., JenaValve Technology Inc., CryoLife Inc., LifeNet Health Inc., Thubrikar Aortic Valve Inc., Colibri Heart Valve, Meril Life Sciences Pvt Ltd, BioTronik, Coroneo Inc., Terumo Corporation, LeMaitre Vascular, MicroPort Scientific Corporation, Nipro Corporation, Shanghai Kindly Medical Instruments Co. Ltd., Others.
“North America” is expected to dominate the market over the forecast period.
The global market is projected to grow at a CAGR of 2.63% during the forecast period, 2025-2034.
The Aortic Valve Replacement Devices Market size was valued at USD 7.26 Billion in 2025.
Proceed To Buy
